Literature DB >> 9783274

Fractionated stereotactic radiotherapy: rationale and methods.

T D Solberg1, M T Selch, J B Smathers, A A DeSalles.   

Abstract

Stereotactic radiosurgery (SRS) has become a widely accepted technique for the treatment intracranial neoplasms. Combined with modern imaging modalities, SRS has established its efficacy in a variety of indications. From the outset, however, it was recognized that the delivery of a single large dose of radiation was essentially "bad biology made better by good physics." To achieve the accuracy required to compensate for this biological shortcoming, the application of SRS has required that a neurosurgical head frame of some sort be rigidly attached to the patients head. Historically, this prerequisite has, primarily for practical reasons, precluded the delivery of multiple fractions over multiple days. With recent improvements in immobilization and repeat fixation, the good biology of fractionated delivery has been realized. This technique, which has come to be known as stereotactic radiotherapy (SRT), has significantly expanded the efficacy of the technique through the use of accurate physical targeting coupled with the basic radiobiological principles gleaned from decades of clinical experience.

Entities:  

Mesh:

Year:  1998        PMID: 9783274     DOI: 10.1016/s0958-3947(98)00016-8

Source DB:  PubMed          Journal:  Med Dosim        ISSN: 1873-4022            Impact factor:   1.482


  3 in total

1.  Long-term remission of primary central nervous system lymphoma by intensified methotrexate chemotherapy.

Authors:  Takao Watanabe; Yoichi Katayama; Atsuo Yoshino; Chiaki Komine; Takakazu Yokoyama; Takao Fukushima
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

2.  Radiosurgery for high-grade glioma.

Authors:  Emanuela Binello; Sheryl Green; Isabelle M Germano
Journal:  Surg Neurol Int       Date:  2012-04-26

Review 3.  Isocenter verification for linac-based stereotactic radiation therapy: review of principles and techniques.

Authors:  Pejman Rowshanfarzad; Mahsheed Sabet; Daryl J O'Connor; Peter B Greer
Journal:  J Appl Clin Med Phys       Date:  2011-11-15       Impact factor: 2.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.